By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to ...

New research shows Ozempic may reduce sleep apnea severity by over 50%. Here's what the science actually says.

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...

AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway ...

Positional therapy can be a long-lasting and effective treatment for patients with positional obstructive sleep apnea (OSA), according to research presented at the 2026 ATS International Conference.

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...

Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, ...

Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The ...

Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.

ResMed (RMD) is in focus after announcing a collaboration with Oura that connects Oura Ring users in the US to ResMed’s sleep education tools, assessments, and potential care pathways for obstructive ...